Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Invested Capital (2016 - 2026)

Neuronetics has reported Invested Capital over the past 11 years, most recently at $13.5 million for Q1 2026.

  • Quarterly Invested Capital fell 66.66% to $13.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.5 million through Mar 2026, down 66.66% year-over-year, with the annual reading at $26.7 million for FY2025, 18.47% down from the prior year.
  • Invested Capital was $13.5 million for Q1 2026 at Neuronetics, down from $26.7 million in the prior quarter.
  • Over five years, Invested Capital peaked at $76.6 million in Q1 2022 and troughed at $9.4 million in Q3 2024.
  • The 5-year median for Invested Capital is $34.2 million (2023), against an average of $41.3 million.
  • Year-over-year, Invested Capital crashed 75.27% in 2024 and then soared 202.27% in 2025.
  • A 5-year view of Invested Capital shows it stood at $70.2 million in 2022, then crashed by 51.29% to $34.2 million in 2023, then decreased by 4.07% to $32.8 million in 2024, then fell by 18.47% to $26.7 million in 2025, then plummeted by 49.46% to $13.5 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's Invested Capital are $13.5 million (Q1 2026), $26.7 million (Q4 2025), and $28.4 million (Q3 2025).